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Objectives. This study assessed the time of first appearance of 
angiograpbic graft coronary artery disease in relation to eiinicai 
and laboratory variables aad clinical events in heart transplant 
recipients. 
Buckground. Graft coronary artery disease is the main factor 
limiting long-term survival after heart transplantation, and it is 
important to understand its natural history. 
progression to ischemic eye&s than the late-onset group (75 
patients), with 3% of the Iate group and only 35% of the early 
group free from ischemic events by 5 years after initial Me&ion 
(p = 0.02), but there were no significantly correlated clinical or 
laboratory predictors of ischemic events. Tbe early group had a 
significantly higher incidence of antecedent cytomegailoviros in- 
fection. 
.Me#zods. One hundred thirty-nine consecutive patients who Conclusions. We eon&de that 1) accelerated grae’t coronary 
developed angiographic coronary artery disease after heart trans- artery disease develops at variable times after heart transplauta- 
plantation were classified according to early (52 years) versus tion; 2) the early appearance of graft coronary artery disease may 
late (>2 years) posttransplantation initial detection of coronary h a marker of intrinsically more aggressive disease; 3) cytomeg- 
artery disease. These subgroups were analyzed for differences in aiovirus infkctioon is associaled with earlier onset of graft coronary 
clinical and laboratory demographics, incidence of progression to artery disease. Patients with early development of graft coronary 
ischemic events and incidence of antecedent qtomegaiovirus artery disease should potentially be given priority for inter/en- 
infection. tional strategies as they are developed. 
Rex&. The early-onset group (64 patients) had more rapid (JAM CM Cardial 19.96$8:673-Y) 
---- --.-~-- 
The occurrence of a diffuse form of coronary intimal thickcn- 
ing in many patients with cardiac allografts has come to be a 
well recognized phenomenon. It is generally agreed that the 
ischemic sequelae of this process are the main complications 
limiting long-term survival in cardiac altograft recipients. The 
diffuseness of the disease makes standard revascularization 
techniques such as angiopiasty and bypass surgery palliative at 
best, and retransplantation is currently the only definitive form 
of therap!r for accelerated aliograft coronary artery disease. 
Because donor resources are limited and results after retrans- 
plantation are less satisfactory than after a firs1 transplant 
procedure (1,2), it is important to understand the natural 
history of accelerated graft coronary artery disease to select 
subsets of patients with the disease who are at highest risk of 
dying of it and who will thus have the greatest benefit from 
retransplantation or from newer interventional therapies. 
graft coronary artery disease might portend a worse prognosis 
and, along with other clinicai or laboratory predictors of 
acce!erated graft coronary artery disease, might identify pa- 
tients at higher risk for ischemic events. We therefore sought 
to 1) evaluate the natural course of the disease, including rts 
progression and sequelae; 2) compare the prognosis of early 
versus late appearance of accelerated graft coronary artery 
disease; and 3) document the incidence of antecedent cyto- 
megalovirus infection associated with early versus late disease 
and the clinical course of patients with coronary artery disease 
with and without cytomegalovirus infection. 
Methsds 
We postulated that early (versus late) onset of accelerated 
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Study patients. The patient data base inchrded 559 consec- 
utive herrt transplant recipients undergoing transplant surgery 
at Stanford between January 1965 and February il)!@. A total 
of402 of these patients survived at least 1 year after transplan- 
tation and had at least one annual coronary arteriogram 
available for review. Two patients, both chiIdren, died sud- 
denly during the first postoperativge year and were found to 
have had accelerated graft coronnty artery disease at autopsy. 
These patients are not included in this anafysis. One hundred 
thirty-nine patients developed imgiographictdly apparent ac- 
celerated graft coronary artery disease during follow-up and 
constitute the shady group. This group was then analyzed 
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according to the time of first detection of accelerated graft 
coronary artery disease, the time to derection of 50% stenosis 
in one or more coronary arteries after initial appearance of 
coronary artery disease, as well as the timing of ischemic events 
after initial detection of accelerated graft coronary artery 
disease, These 139 patients were classified into two groups on 
the basis of arbitrarily defined criteria of early versus lete 
appearance of accelerated graft coronary artery disease. The 
ear& grump was defined as those patients who developed 
accelerated graft coronary artery disease 52 years postopera- 
tively, and those who developed accelerated graft coronary 
artery disease >2 years postoperatively were defined as tiae lute 
group. There were 64 patients in the early group (mean time of 
detection of graft coronary artery disease 1.5 years after 
transplantation, range 0.7 to 2.0) and 75 in the late group 
(mean time of detection 4.9 years after transplant&on, range 
2.3 to 17). These groups were compared for digerences in 
clinical outcome as well as possible risk factors for the occur- 
rence or progression of accelerated graft coronary artery 
disease. 
Three patients had preexisting angio&Taphic oionary dis- 
ease on their predischarge (baseline) angiogram, o:je with 20% 
stenosis in the e&y group, and two with 20% and 40% stenosis 
in the l&e group. These three patient had the appearance of 
new lesions as well as progression of preexisting disease on 
their follow-up angiograms. 
The incidence of cytomegalovirus infection in these patients 
was reviewed. Ninety-two of 139 patients were treated during 
the cyclosporine era of immunosuppression and had complete 
cytomegaiovirus infection information for analysis. These 92 
pat&s were also classified into groups according to the 
presence or absence of evidence of postoperative cytomegalo- 
virus infect.ion, and these groups were compared for differ- 
ences in clinical outcome iYytomegalovirus data were not 
available for patients operated on before 1980; therefore, 47 of 
the original 139 could not be included in this analysis. 
Cardiac catheterization. Nl patients were evaluated annu- 
ally near the anniversary of their transplant procedure with 
right and left heart catheterization and selective coronar)l 
arteriography using the percutaneous femoral approach and 
standard angiographic techniques. Written informed consent 
was obtained from ail patients under Stanford Institutional 
Review Board guidelines. 
Criteria for diagnosis of transplant coronary artery dis- 
ease. A diagnosis of acceleruted graj? coronas artery disease 
was made if any angiographic evide:lce of coronary artery 
narrowing was seeu., whether in protimal or distal branches. 
Serial tine films were compared using two projectors for side 
by side comparisons, and arterial lesions were classified as 
250% or ~50% diameter stenosis. The presence or absence of 
disease and the classification of lesions were determined by a 
consensus of two angiographers (S.Z.G., E.L.A.), The side by side 
seriai comparisons made possible not only the recognition of focal 
atherosclerotic-type l sions, but also the recognition of the diiuse 
concentric narrowing in the mid to distal artery and distal 
“pruning” of vessels characteristic of accelerated graft coronary 
artcly disease; changes that otherwise could be easily missed. 
Since 1986, baseline coronag’ angiograms have been obtained 
routinely in patients with implanted hearts within a few weeks 
after transplantation. If any evidence of coronary artery dis- 
ease existed on the baseline studies, accelerated graft coronary 
artery disease was defined as evidence of new abnormalities in 
different locations or progression of a previously existing 
stenosis. Qsantitative angiography was not used for this study. 
Criteria for diagnosis of cytomegalovirus infection. Qto- 
megalovirus infection was defined for purposes of this study as 
either seroconversion of a previously cytomegalovirus- 
seronegative patient, a fourfold increase in a previously posi- 
tive cytomegalovirus immunoglobulin C titer, positive cultures 
for cytomegalovirus. demonstration of cytomegalovirus inclu- 
sion in tissue specimens or a clinical illness documented to be 
due to cytomegalovirus. As previously staled, such data were 
not routinely collected before 1980 and thus were not available 
for 47 of the 139 patients. 
Clinical events. Clinical findings that were considered isch- 
emit events included clinical evidence of myocardial infarc- 
tion, clear-cut electrocardiographic evidence of new myocar- 
dial infarction with or without a clinical event, pathologic 
findings of infarction in explanted hearts or postmortem 
specimens, the development of congestive heart failure unre- 
lated to cellular or vascular rejection, retransplantation for 
accelerated graft coronary artery disease and sudden death. 
Immunosuppressive protocols. Different immunosuppres- 
sive protocols were used seqnentiaiiy throughout the evolution 
of the Stanford program. Protocols used azathioprine and 
prednisone between 1968 and 1979: cyciosporine and pred- 
n&one between 1980 and 1983 and triple immunosuppression 
with cyclosporine, azathioprine and prednisone between 19133 
and 1990. In addition, anti-T cell (induction) therapy protocols 
used antilymphocyte globulin between 1968 and 1974, horse or 
rabbit antithymocyte globulin between 1974 and 1976, rabbit 
antithymocyte globulin between 1980 and 1984, horse antithy- 
mocyte globulin between 1985 and 1987 and OKT3 between 
1987 and 1990. All patients received aspirin and dipyridamole.- 
From 1986 to February 1990, patients who consented were 
randomized to receive diltiazem or no calcium channel block- 
ing agent shortly after operation. Preliminary results of the 
e!fects of calcium channel blockers have been reported sepa- 
rately (3). In the current analysis, four patients (5.3%) in the 
late group and three (4.7%) in the early group were taking 
calcium channel blockers. 
Other clinical risk factors. Comparisons between the two 
groups were made with regard to a number of possible clinical 
risk factors. These included recipient and donor age and 
gender, number of human leukocyte antigen (HLA) mis- 
matches, number of treated rejection episodes during the first 
year after transplantation and graft ischemic time. They also 
included time-related systemic blood pressure, daily doses of 
the various immunosuppressive agents and lipid values. Data 
for donor/recipient race and HLA-DR matching and use of 
lipid-lowering therapy are not available for the majority of 
these patients. 
Statistical. ana$sis. izpl results are presented as mean 
value 2 SD. The Kaplan-Meier mcihocl was used to calculate 
probability of freedom from the first appearance of graft 
coronary artery disease on angiograph:i after tra~~s~Ia~,ta~~Gn~ 
50% diameter stenosis of one 6:. mom coronary arteries and 
cliflicaf ischemic event after initial detection of graft coronary 
artery disease. The Mantel-H;enzel log-rank test was used to 
compare the equality of survival curves between early and late 
groups. Differences between the group characteristics were 
assessed with the chi-square test for categoric variables and 
two-tailed t tests for continuous variables. Multivariate logislic 
regression analysis was used to identify predictors for ischemic 
events. A p value <0.05 was considered rtatistically signifi- 
cant. 
&?sults 
The clinical characteristics of patients with early versus late 
appearance of transplant coronary artery disease are compared 
in Table 1. Patients with early appearance tended to be older, 
had received hearts from older donors and had lower high 
density lipoprotein (HDL) cholesterol blood levels. 
TnitiaI appearance. Time-related freedom from any angio- 
graphic appearance of accelerated graft coronary artery dis- 
ease for the whole group of 139 patients who had documented 
graft coronary artery disease was analyzed. Initial detection of 
graft coronary artery disease occurred in ?l%, 56% and 83% 
of this group at I, 3 and 5 years after transplantation, rcspec- 
tively. This result shows that 50% of all patients who by 
definition eventually develop accelerated graft coronary artery 
disease by 3 years after operation. 
Ischemic events after initial appearance of acceleriited 
graft coronary artery disease, At initial deteciion of acceler- 
ated graft coronary artery disease, 4.5 (32%) of 139 patients 
already had at least one lesion judged to be ~5070 obstructive. 
By 2 years after initAi detection, an additional 1’7% of patients 
had developed 250% stenosed lesions (Fig. 1). Figure 1 also 
shows the incidence of ischemic events after initial detection of 
any accelerated graft coronary artery disease, displayed as an 
actuarial curve of freedom from ischemic events Several 
patients underwent arteriography because of the occurrence of 
an ischemic event. For this reason, freedam from ischemic 
events at “‘time zero,” in time of detection of disease, is 
<lOO%. At 1, 3, and 5 years after initial appearance of 
accelerated graft coronary artery disease, 23%, 43% and 53% 
of patients had sustained ischcmic events, respectively, and 
50% of all patients had an isclhemic event :+ithin 4 years of 
disease detection. 
Ninety-five ischemic complications occurred in 66 patients 
and included 16 patients with congestive heart failure, 27 with 
myociirdial infarcticn, 34 with retransplantation for severe 
coronary artery disease and 18 with sudden death. Eighty-two 
of the 139 patients have died (graft coronary artery disease in 
60 [73.2%], infection in 14 [17.1%], Iymphoproliferative dis- 
ease in 1 [1.2%], nonspecific graft failure in 2 [2.4%]1 pulmo- 
nary embolism in 1 [1.2%], other causes in 4 [4.9%]). 
Freedom from ischemic events: ear@ versus late groups. 
Figure 2 presents data on freedom from ischemic events after 
iuitial detection of accelerated graft coronary artery disease for 
the early- and late-anpearancr groups. The two groups appear 
to be parallel in their rate of developing ischemic events for the 
brst 2 years after detedion, but diverge markedly after il years, 
with 59% of the late group and only 34% of the c&y group 
free of ischemic events by 5 years after imtia! detection, These 
curves were significantly different at the p = 0.02 level. 
Relatioa to cyttrmegalovirus infection. Because there is a 
well recognized association between the occurrence of cyto- 
megalovirus infection and the incidence of xx&rated graft 
coronary artery d&se, we analvzed this group mT patients to 
determine whether cytomegalo\;irus infection 5~s associated 
with early versus late development of disease. There was no 
difference in the prevalence of preoperative donor or recipient 
seropositivity for cytomegalovirus infection between the early 
and late groups. Table 2 shows the ear& and late groups of 
patients classified into subsets according to the presence or 
absence of postoperative cytomegalovirus kfection. 
Our data show that 66% (21 of 32) of i&e early and only 
34% (1 I of 32) of the late graft coronary artery disease-onset 
group had evidence of antecedent cytomegalovirus infection 
(p = 0.02). If one considers only symptomatic cytomegalovirus 
infections, the percenmges are 93% (13 of 14) for the early 
group and 7% (1 of 14) for the late group (p = 0.0067). 
The post-1980 patient group was classified into 32 patients 
who had evidence of cytomegalovirus infection and 50 who did 
not. Compartsoii of freedom from ischemic events for these 
two overall groups did not reach statistical significance. 
Muftivariate regression ana!ysis for predictors of ischemic 
events. Clinical variables, including recipient and donor age; 
ischemic time; systolic and diastolic blood pressures; incidence 
of serologic and symptomatic cytomegalovirrts infection after 
transplantation; number of rqjection episodes; prednisone, 
azathioprine and cyclosporine dosage; plasma concentrations 
of triglycerides, total serum cholesterol> low density lipoprotein 
cholesterol, HDL cholesterol and very low density hpoprotein 
cholesterol, were analyzed by multivariate logistic regression 
analysis. Only a somewhat lower c~~lospori~~~ dosage (p = 
0.02) was a statistically signibcant predictor of ischemic events. 
Angiographicaily apparent accelerated graft coronary ar- 
tery disease is generally agreed to have a prevalence of --SO%> 
by S years after transplantation (4-h), and the prevalence is 
expected to approach 100% in truly long-term survivors. 
Standard angiographic techniques clearly underestimate the 
occurrence and extent of the disease (S-9). In one study (IO), 
60 patients evaluated by intracoronary ultrasound ~1 years 
after trallspla~ltation all had at least minimal intimal thicken-. 
ing. Studies of autopsy specimens suggest that the incidence of 
histologically evident coronary intimal thickening is lOtI% by E 
year after transplantation (11). Given the universal occurrence 
of this process and the eventually Icthal seyuefac of irs 
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Figure 1. Time-related percent of freedom from 5t)% 
&meter stenosis and ischemic wents after initial detcc- 
tion of accelerated graft coronary artesy disease (CAD): 
33% of patients (45 of 139) had :x50% diameter stenosis 
at initial detection, and 4% (5 of 139) experienced isch- 
emit events simultaneously with first detection. 
progression. it is important to understand its natural history 
and identify subsets of patients most in need of retransplanta- 
tion or (eventually) other types of interventional therapy. 
Graft cormmy artery disease-high risk subgroups. In 
the current analysis we take a different approach by concen- 
trating on the subgroup of our patients known to have angio- 
graphic evidence of some graft coronary artery disease and 
determine which features are associated with th< worst prog- 
nosis. En an ear&r analysis of the same group (12): wc found 
that the rapidity of angiographic progression of accelerated 
graft coronary artery disease did portend the d~ve!opment of 
an ischemic event. ‘The current study suggests lhat an earlier 
appearance of accelerated graft coronary artery disease and an 
association with cytomegalovirus infection may also be mark- 
ers of intrinsically more aggressive disease. 
Graft coronary artery &seas*risk factahs for early ap 
pcarance. It has been difhcuh to identify clInicat or laboratory 
correlates to predict very accurately which patients will de- 
velop accelerated graft coronary artery disease (B-15). Nei- 
ther the type of original heart disease (atherosclerotic vs. 
other), nor any of the standard risk factors are helpful pro- 
spectively to identify patients at high risk for the disease. 
Several centers have reported a much higher incidcncc of 
accelerated graft coronary artery disease in patients 
with (~yt~~megaI~~irus infection (I&-I9), but whether 
cytomegalovirus-related coronary artery disease occurs ear- 
lier (or has a worse prognosis) has not been previously 
assessed. In the present analysis, cytomegalovirus infection 
is significantly correlated with early angiographic appear- 
ance of graft coronary artery disease. There is a suggestion 
that more advanced age of both the donor and recipient is 
also associated with the early appearance of coronary artery 
disease, There is evidence that hearts from older donors: 
particularly those with risk factors, may have preexisting, 
angiogra~th~~~lly inapparent, coronary artery disease (1Q). 
Whether these preexisting Iesions become the substrate for 
more rapid later progression remains to be evaluated. In the 
present study, new-onset and progression of coronary artery 
disease ~‘LI follow-up angiograms were required to be incrc- 
mental to preexisting donor disease, which was angiographi- 
callp detectable in only 3 of the 139 patients. 
The association between earlier onset of angiographic 
coronary artery disease and subsequent earlier devetopment of 
lesions and ischemic events seems predictable and senies the 
goat of identifying those patients for whom more aggressive 
and earlier treatments might be initiated to mitigate this 
process. These high risk patients (with early appearance and 
rapid progression of accelerated graft coronary artcy disease) 
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do. of years after initial de!ection of graft CAD 
Figure 2. Comparison of time-related percent of freedom from isc!l- 
emit events in the early (circles) and iate (diamonds) groups: 5% (3 of 
64) of the early and 3% (2 of 75) of the lete group experienced an 
ts&mic event simultaneously with first deiection of coronary artery 
disease (CAD). 
wocid also be prime targets for future clinical trials of any 
proposed therapeutic modalities. 
Surveillance angiugraphy. The need to continue annual 
ccironary angiography if the results of first angiogram are 
normal has been questioned by some (20). The present study 
soygests that even though ischemic sequelae are less frequent 
in &e-onset graft coronary artery disease, such sequelae do 
occur frequently, and prospective awareness of a patient’s risk 
for sustaining them may be valuable knowledge. 
Condasions. Accelerated graft coronary artery dii;ease 
seems to develop at variable times after transplantation, and 
about one-third of patients show severe stenosis when core- 
nary artery disease is initially detected. The early appcarnncc 
Table 2. Comparison of Posttransplant Cytomegalovirus Infection in 
Early Versus Late Graft Coronary Artery Disease Groups 
Cytomegalovirus P 
Infection* Early Group Late Group Value 
No (I1 = 60) 23160 (38%) 37160 (63%) 0.02 
Yes (n = 32) 21132 (66%) 11132 (34%) -I__ i 
*Fourfold immunogl~b~~lin G anti-cytomegalovirus antibody titer increase, 
positive culture for qtomegalovirus, cytomr,galovirus inclusion body in tissue. 
Table 3. Comparison of Pretransplant Sempositivity ill Early Versus 
Late Graft Coronary z4rtery Disease Croups 
of accelerated graft coronary artery disease may be a marker of 
intrinsically more aggressive disease. Cytomegalovirus infec- 
tion is associated with early onset of graft coronary artery 
disease. Patients with early development of coronary artery 
disease are potential priority candidates for interventional 
strategies as they are developed. 
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